Follow us:

News

  • Home
  • News & informations

Launch of Ypso-Ionic 2021, the software solution for designing chromatographic processes

Including ion exchange, adsorption, affinity, hydrophobic interactions, size exclusion, ion exclusion, chelation...

  • by Ypso-Facto
  • October 28, 2021
We are delighted to announce the launch of Ypso-Ionic ® 2021, the first commercial application of the Proxima software suite! Maximize the value of your data Embrace the power of mechanistic simulation Open up a new world of opportunities for your chromatographic processes! ...

Read more


PRESS RELEASE : Ypso-Facto is part of the CALIPSO project led by Sanofi, to disrupt the production of biomedicines!

Supported by Bpifrance, the CALIPSO project aims at developing a new generation of tools that will disrupt industrial bioproduction processes.

  • by Ypso-Facto
  • September 16, 2021
  Nancy, France, 16 Sept 2021 - Ypso-Facto is proud to play a major role in this challenging and exciting project. With its expertise in bioprocesses and predictive simulation , Ypso-Facto will develop software solutions to support production of innovative therapies. The company will work on...

Read more


CALIPSO: revolutionizing the management of bioproduction processes in healthcare

Paris (France) – September 16th, 2021 – Sanofi, Capgemini, Ypso-Facto, GPC Bio, CEA, CentralSupelec announce the launch of the project CALIPSO !

  • by Ypso-Facto
  • September 15, 2021
  A structuring R&D project for French medical research, financed and coordinated by a consortium of high-profile industrial and public actors. An essential mobilisation to accelerate access to new treatments at an acceptable cost, to ensure France’s competitiveness and its health independence...

Read more


Ypso-Facto invests 1.4M€ in the development of a collaborative software suite for process design and evaluation

The company has received 800k€ from European Regional Development Fund (ERDF) to support the development of Ypso-Proxima®

  • by Ypso-Facto
  • January 14, 2021
Nancy, France, January 14th, 2021 - Ypso-Facto, a company specialized in the development and optimization of processes for the Life Sciences Industries invests 1.4M€, including € 800,000 from the European Regional Development Fund (ERDF), to support the development of its software suite Ypso-Proxima®...

Read more


NEW ARTICLE - Comparison of mAb single-use DSP processes by Sanofi using Ypso-Proxima

EASY: a disruptive mAb purification process to reduce cost of goods

  • by Ypso-Facto
  • January 08, 2021
This article [1] illustrates how Ypso-Proxima allows a rational comparison between two biopharmaceutical DSP processes. The innovative EASY mAb purification process developed by Sanofi is matched against the standard proteinA-based DSP counterpart. Relying on Proxima's process evaluation, the...

Read more


NEW ARTICLE – Fareva and Ypso-Facto investigate the purification of an antibiotic by ion-exchange

Using Mechanistic Modeling for Understanding Antibiotics Purification with Ion Exchange Chromatography

  • by Ypso-Facto
  • November 02, 2020
This article is based on a real industrial purification process by Fareva and highlights the power of mechanistic modeling for process development: Our client needed to change a raw material to secure his supply chain. From a process point of view, it was supposed to be seamless. However, a...

Read more


Indépendance sanitaire : La tribune de Roger-Marc Nicoud

“ Retrouver l’indépendance pour la production d’API : une chance pour les CDMO européennes ? "

  • by Ypso-Facto
  • May 13, 2020
La crise actuelle rappelle à l’Europe (et sans doute à l’Amérique du Nord) les limites de la délocalisation de la production. C’est le cas pour de nombreux produits, incluant bon nombre d’ingrédients pharmaceutiques actifs (API) et de médicaments en général. Cela ouvre la possibilité...

Read more


Feature article – Regaining independence in API production: A chance for European CDMOs

Roger-Marc Nicoud, CEO of Ypso-Facto, looks at the challenges and opportunities for CDMOs in the current crisis

  • by Ypso-Facto
  • May 12, 2020
The current crisis has highlighted the dependence of European and, indeed, North American countries on delocalised production. This is the case for many goods, including APIs and drugs in general. The opportunity is now there for European CDMOs to win additional business, but effort and adaptation...

Read more


Ypso-Facto is a service company helping industrial firms to develop, optimize and secure their chemical processes and bioprocesses.

Learn more

Contact Us
© Ypso-Facto 2014 - Powered by Ealys | Legal Information